Related Experiment Video
Updated: Jul 2, 2026

08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Advances in non-viral gene delivery: using multifunctional envelope-type nano-device
Hidetaka Akita1, Hideyoshi Harashima
1CREST Japan Science and Technology Agency (JST), Japan.
Expert Opinion on Drug Delivery
|August 21, 2008
Summary
Multifunctional envelope-type nano-devices (MENDs) integrate multiple components to overcome intracellular barriers in gene delivery. A key finding is that post-nuclear delivery is a critical rate-limiting step for non-viral gene vectors.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Low transfection efficiency of non-viral gene vectors hinders clinical applications.
- Effective non-viral vectors necessitate controlled intracellular trafficking for nuclear DNA delivery.
Purpose of the Study:
- To overcome intracellular barriers by integrating functional devices into single nanoparticles.
- To understand rate-limiting processes in intracellular trafficking using quantitative information.
Main Methods:
- Review of advancements in multifunctional envelope-type nano-devices (MENDs).
- Description of a novel method for quantitatively evaluating rate-limiting steps in intracellular trafficking.
- Comparison of viral and non-viral gene delivery systems.
Main Results:
- Multifunctional envelope-type nano-devices (MENDs) enable the integration of diverse devices to overcome cellular barriers.
- Quantitative evaluation of intracellular trafficking reveals key bottlenecks.
- Comparison with adenoviruses highlights post-nuclear delivery as a critical step for non-viral vectors.
Conclusions:
- MENDs are effective platforms for integrating devices to overcome intracellular barriers.
- Post-nuclear delivery is identified as a significant rate-limiting step for efficient non-viral gene transfection.
- Understanding intracellular trafficking is crucial for improving non-viral gene delivery systems.
